These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9266106)

  • 41. High-level expression of the CD44 variant sharing exon v10 in renal cancer.
    Kan M; Aki M; Akiyama K; Naruo S; Kanayama H; Kagawa S
    Jpn J Cancer Res; 1995 Sep; 86(9):847-53. PubMed ID: 7591962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene.
    Yoshida K; Sugino T; Bolodeoku J; Warren BF; Goodison S; Woodman A; Toge T; Tahara E; Tarin D
    J Clin Pathol; 1996 Apr; 49(4):300-5. PubMed ID: 8655705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
    Tempfer C; Sliutz G; Haeusler G; Speiser P; Reinthaller A; Breitenecker G; Vavra N; Kainz C
    Br J Cancer; 1998 Oct; 78(8):1091-4. PubMed ID: 9792156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
    Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
    Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
    Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast.
    Berner HS; Nesland JM
    Breast Cancer Res Treat; 2001 Jan; 65(1):23-9. PubMed ID: 11245336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of CD44 isoforms in human renal cell carcinomas.
    Heider KH; Ratschek M; Zatloukal K; Adolf GR
    Virchows Arch; 1996 Jul; 428(4-5):267-73. PubMed ID: 8764936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
    Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
    J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
    Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
    Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma.
    Hong RL; Pu YS; Chu JS; Lee WJ; Chen YC; Wu CW
    Cancer Lett; 1995 Feb; 89(1):81-7. PubMed ID: 7533658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer.
    Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C
    Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA.
    Loh TJ; Moon H; Cho S; Jung DW; Hong SE; Kim DH; Green MR; Zheng X; Zhou J; Shen H
    Oncol Rep; 2014 Jan; 31(1):273-9. PubMed ID: 24173428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.
    Lü X; Xu K; Lü H; Yin Y; Ma C; Liu Y; Li H; Suo Z
    Ultrastruct Pathol; 2011 Apr; 35(2):72-8. PubMed ID: 21299347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
    Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T
    Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
    Kryworuckho M; Diaz-Mitoma F; Kumar A
    Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD44 and the adhesion of neoplastic cells.
    Rudzki Z; Jothy S
    Mol Pathol; 1997 Apr; 50(2):57-71. PubMed ID: 9231152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD44 variant isoform expression and breast cancer prognosis.
    Tokue Y; Matsumura Y; Katsumata N; Watanabe T; Tarin D; Kakizoe T
    Jpn J Cancer Res; 1998 Mar; 89(3):283-90. PubMed ID: 9600122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expression of CD44 and isoforms v4, v5, v6, v7, v10--new prognostic parameters in ductal pancreatic carcinoma?].
    Böttger T; Maschek H; Gottwald W; Lobo M; Brenner W; Junginger T
    Chirurg; 1998 Oct; 69(10):1089-92. PubMed ID: 9833191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [CD44 splice variants as prognostic factors in invasive cervix carcinoma].
    Reinthaller A; Kainz C; Kohlberger P; Tempfer C; Gitsch G; Kölbl H; Breitenecker G
    Gynakol Geburtshilfliche Rundsch; 1995; 35(1):16-9. PubMed ID: 7537136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.
    Iida J; Clancy R; Dorchak J; Somiari RI; Somiari S; Cutler ML; Mural RJ; Shriver CD
    PLoS One; 2014; 9(2):e88712. PubMed ID: 24586375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.